ATCC, a nonprofit biomaterials company, has announced 30 new collaborations with leading public and private research institutions. Under the agreement, ATCC will coordinate with each institution’s tech transfer office to develop a simple, efficient way to adopt new microbial strains and cell lines to ATCC’s collection. In return, many of the institutions will be granted a share of the revenue from ATCC products that were based on their research.
So far, more than 225 unique biological materials are deposited under these new agreements. Many of these are available through the Biomaterial Contributor Network (BCN), an open-sharing community for researchers, which ATCC offers as an option to the contributing institutions.
“These agreements reinforce ATCC’s mission to distribute scientifically valuable, authenticated materials, while recognizing the shared financial benefit with participating institutions,” says Dr. Raymond Cypess, CEO of ATCC.
The 30 partnering institutions include both government agencies such as the Centers for Disease Control (CDC) and the Food and Drug Administration (FDA); and academic institutions including Johns Hopkins University School of Medicine, the Massachusetts Institute of Technology (MIT) and Michigan State University. TTOs wanting more information about the ATCC Biomaterial Contributor Network can visit http://www.atcc.org/bcn.
Source: PR Web